The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy.
 
Tora S. Solheim
No Relationships to Disclose
 
Barry J A Laird
Honoraria - Artelo Biosciences; Artelo Biosciences; Kwona Kirin; Nutraponia; Nutricia; Toray Industries
Consulting or Advisory Role - Actimed Therapeutics; Artelo Biosciences
 
Trude R. Balstad
No Relationships to Disclose
 
Guro Birgitte Stene
No Relationships to Disclose
 
Vickie Baracos
No Relationships to Disclose
 
Asta Bye
No Relationships to Disclose
 
Olav Dajani
No Relationships to Disclose
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Amgen; Faraday Pharmaceuticals; Ipsen; Merus; Novartis; Pancreatic Cancer Action Network; Regeneron; Valar Labs; Varian Medical Systems
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - Rayzebio
 
Florian Strasser
Honoraria - Pfizer, Helsinn
Research Funding - swisscancerfoundation (Inst)
 
Martin Robert Chasen
No Relationships to Disclose
 
Matthew Maddocks
Honoraria - AstraZeneca
Consulting or Advisory Role - Helsinn Therapeutics
 
Melanie R. Simpson
No Relationships to Disclose
 
Eva Skovlund
No Relationships to Disclose
 
Gareth Owen Griffiths
Research Funding - Director of the Southampton Clinical trials Unit which is core funded by Cancer Research UK and part-funded by the NIHR. As Director I have received funding from Janssen-Cilag, AstraZeneca, Novartis, Astex, Roche, Heartflow, Celldex, BMS, BioNTech, MSD, I (Inst)
Other Relationship - I have received payment for running and presenting CPD training events for early career researchers at AZ and Abbvie hosted workshops. I have also received honorarium from the Irish Cancer Society for involvement in their fellowship funding committee
 
Jonathan Hicks
No Relationships to Disclose
 
Janet Shirley Graham
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; nucana
Consulting or Advisory Role - Merck KGaA
Travel, Accommodations, Expenses - nucana
 
Fiona Kyle
Travel, Accommodations, Expenses - Novartis
 
Joanna Bowden
No Relationships to Disclose
 
Marie T. Fallon
Research Funding - Mentholatum (Inst); Pfizer (Inst)
 
Stein Kaasa
No Relationships to Disclose